脑部放疗前后标准化神经认知评估的临床实施
本研究描述了2019年4月至2021年12月接受脑部放疗患者标准化神经认知评估的实施与依从性,基线和随访时分别进行三项神经认知测试,基线644例、6个月346例、1年205例,依从率分别为90.4%、85.6%、75.3%。1年时26%的患者至少一项变量显著下降,49%至少一项变量认知表现提高。
要点
- 标准化神经认知测试在放疗科成功实施,患者依从性高,基线、6个月、1年依从率分别为90.4%、85.6%、75.3%。
- 1年时26%患者至少一项变量显著下降,11%至少两项变量显著下降;49%至少一项变量提高,22%至少两项变量提高。
- 开发了半自动分析方法评估认知变化,数据收集仍在进行,将进行长期随访(至治疗后5年)和剂量效应分析。
核心结论
- 标准化神经认知测试在放疗科成功实施,患者依从性高,并定义了评估治疗后认知变化的半自动方法。
- 数据收集仍在进行,将进行长期随访(至治疗后5年)和剂量效应分析。
研究设计与样本
- 纳入2019年4月至2021年12月接受脑部放疗(神经、头颈和预防性颅脑照射)的患者。
- 进行三项神经认知测试:霍普金斯词语学习测验(HVLT)、控制性口语词语联想测验(COWAT)和连线测验A&B(TMT A&B)。
- 测试在放疗开始前、放疗后6个月和1年进行,使用文献参考数据计算基线与随访之间的可靠变化指数(RCI)。
主要发现
- 基线644例患者完成神经认知测试,6个月346例,1年205例,依从率分别为90.4%、85.6%、75.3%。
- 不依从原因:患者未赴约49%,因病无法完成测试12%,拒绝测试8%,其他原因31%。
- 1年时26%的患者至少一项变量显著下降,11%至少两项变量显著下降。
- 1年时49%的患者至少一项变量认知表现提高,22%至少两项变量认知表现提高。
关键数值与推荐
- 1年时26%的患者至少一项变量显著下降,11%至少两项变量显著下降。
- 1年时49%的患者至少一项变量认知表现提高,22%至少两项变量认知表现提高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 数据收集仍在进行,长期随访(至治疗后5年)和剂量效应分析将后续进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiotherapy induced impairment of cognitive function can lead to a reduced quality of life. The aim of this study was to describe the implementation and compliance of standardized neurocognitive assessment. In addition, the first results of cognitive changes for patients receiving a radiation dose to the brain are described. MATERIALS AND METHODS: Patients that received radiation dose to the brain (neuro, head and neck and prophylactic cranial irradiation between April-2019 and Dec-2021 were included. Three neuro cognitive tests were performed a verbal learning and memory test, the Hopkins Verbal Learning Test; a verbal fluency test, the Controlled Oral Word Association Test and a speed and cognitive flexibility test, the Trail Making Test A&B. Tests were performed before the start of radiation, 6 months (6 m) and 1 year (1y) after irradiation. The Reliable Change Index (RCI) between baseline and follow-up was calculated using reference data from literature. RESULTS: 644 patients performed the neurocognitive tests at baseline, 346 at 6 months and 205 at 1y after RT, with compliance rates of 90.4%, 85.6%, and 75.3%, respectively. Reasons for non-compliance were: 1. Patient did not attend appointment (49%), 2. Patient was unable to perform the test due to illness (12%), 3. Patient refused the test (8 %), 4. Various causes, (31%). A semi-automated analysis was developed to evaluate the test results. In total, 26% of patients showed a significant decline in at least one of variables at 1y and 11% on at least 2 variables at 1y. However, an increase in cognitive performance was observed in 49% (≥1 variable) and 22% (≥2 variables). CONCLUSION: Standardized neurocognitive testing within the radiotherapy clinic was successfully implemented, with a high patient compliance. A semi-automatic method to evaluate cognitive changes after treatment was defined. Data collection is ongoing, long term follow-up (up to 5 years after treatment) and dose-effect analysis will be performed.
引用
- Zegers CML, Offermann C, Dijkstra J, et al. Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain. Clin Transl Radiat Oncol. 2023. PMID: 37576068. doi:10.1016/j.ctro.2023.100664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。